Factor | All participants Na (%) | Adequate immune response nb (%) | P value |
---|---|---|---|
Male | 68 (42.2) | 66 (97.1) | 0.750 |
Younger age (6Â months) | 79 (49.1) | 79 (100) | 0.001 |
Mother attaining secondary Education | 95 (59) | 94 (98.9) | 0.356 |
Born to Chronic HBVc carrier | 12 (7.5) | 12 (100) | 0.548 |
Received HBVc vaccine at Birth | 12 (7.5) | 12 (100) | 0.548 |
Received HBIGd at birth | 4 (2.5) | 4 (100) | 0.438 |
Born at term | 149 (92.5) | 146 (98) | 0.643 |
Normal Birthweight | 138 (85.7) | 134 (97.1) | 0.710 |
Neonatal Infection | 18 (11.2) | 18 (100) | 0.472 |
Documented febrile illnesses | 47 (29.2) | 47 (100) | 0.193 |
Mother HIV positive | 6 (3.7) | 6 (100) | 0.690 |
Adequate weight for height for age | 139 (86.3) | 135 (97.1) | 0.723 |
Duration since last vaccine dose > 3 months | 82 (50.9) | 80 (97.4) | 0.029f |
Follows EPIe strictly | 131 (81.4) | 128 (97.7) | 0.741 |